Osaic Holdings’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-287
Closed -$5.04K 7304
2023
Q4
$5.04K Buy
287
+258
+890% +$4.61K ﹤0.01% 6172
2023
Q3
$515 Sell
29
-1
-3% -$18 ﹤0.01% 6981
2023
Q2
$541 Buy
30
+1
+3% +$20 ﹤0.01% 7033
2023
Q1
$595 Hold
29
﹤0.01% 7089
2022
Q4
$1K Hold
29
﹤0.01% 6898
2022
Q3
$1K Hold
29
﹤0.01% 7007
2022
Q2
$1K Hold
29
﹤0.01% 7098
2022
Q1
$1K Sell
29
-193
-87% -$4.74K ﹤0.01% 7068
2021
Q4
$6K Sell
222
-150
-40% -$5.16K ﹤0.01% 6544
2021
Q3
$14K Sell
372
-1,659
-82% -$64.7K ﹤0.01% 6013
2021
Q2
$92K Buy
2,031
+470
+30% +$20K ﹤0.01% 4551
2021
Q1
$61K Sell
1,561
-248
-14% -$10.1K ﹤0.01% 4735
2020
Q4
$71K Sell
1,809
-637
-26% -$22.5K ﹤0.01% 4299
2020
Q3
$83K Buy
2,446
+2,063
+539% +$70.6K ﹤0.01% 3960
2020
Q2
$12K Buy
383
+209
+120% +$5.73K ﹤0.01% 5093
2020
Q1
$4K Buy
+174
New +$4.23K ﹤0.01% 5444

Other funds holding KURE

Osaic Holdings's KURE Position: Q1 2024 in Review

Osaic Holdings sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q1 2024, closing a stake of 287 shares — an estimated $5.04K sold.

Osaic Holdings first reported a position in KURE in Q1 2020 and held it in 16 quarters. The position peaked at $92K in Q2 2021. 14 funds tracked by Wall St. Rank hold KURE as of Q1 2024.

  • Osaic Holdings reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q1 2024 after selling out during the quarter.
  • Osaic Holdings sold 287 KraneShares MSCI All China Health Care Index ETF shares in Q1 2024, an estimated $5.04K.
  • Osaic Holdings first reported a position in KraneShares MSCI All China Health Care Index ETF in Q1 2020 and held it in 16 quarters.
  • Osaic Holdings's KraneShares MSCI All China Health Care Index ETF position peaked at $92K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.